These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 24935058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G, Torti S, Pezzini C, Vassallo C, Rosso R, D'Ospina RM, Tomasini C, Brazzelli V.
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL, Pillow MT.
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
    Sarajärvi P, Kubin M, Tasanen K, Huilaja L.
    Duodecim; 2017 Jan; 133(1):43-51. PubMed ID: 29199808
    [Abstract] [Full Text] [Related]

  • 8. Antiepileptic drug-induced hypersensitivity syndrome with liver function abnormality and fever as the first manifestation: A case report.
    Liu M, Ci XY, Huang H, Zhang MJ.
    Medicine (Baltimore); 2023 Jan 20; 102(3):e32657. PubMed ID: 36701733
    [Abstract] [Full Text] [Related]

  • 9. Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill.
    Halink DA, Marijnissen RM, Schut AA, Oude Voshaar RC.
    Gen Hosp Psychiatry; 2011 Jan 20; 33(4):412.e5-8. PubMed ID: 21762844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
    E L omairi N, Abourazzak S, Chaouki S, Atmani S, Hida M.
    Pan Afr Med J; 2014 Jan 20; 18():9. PubMed ID: 25360193
    [Abstract] [Full Text] [Related]

  • 12. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S, Iriki H, Asahina Y, Furuichi Y, Funakoshi T, Ichikawa M, Mikami Y, Okita H, Sakiyama T, Inazumi T, Amagai M, Takahashi H.
    J Dermatol; 2022 Aug 20; 49(8):796-799. PubMed ID: 35502510
    [Abstract] [Full Text] [Related]

  • 13. DRESS Syndrome or Hematologic Malignancy?: A Case Report of a 4-Year-Old Boy.
    Besli GE, Yildirim S, Yilmaz K, Yuksel E.
    Pediatr Emerg Care; 2017 Jul 20; 33(7):494-496. PubMed ID: 28665895
    [Abstract] [Full Text] [Related]

  • 14. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
    Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC, RegiSCAR study group.
    Br J Dermatol; 2013 Nov 20; 169(5):1071-80. PubMed ID: 23855313
    [Abstract] [Full Text] [Related]

  • 15. DRESS syndrome: a detailed insight.
    Behera SK, Das S, Xavier AS, Selvarajan S.
    Hosp Pract (1995); 2018 Aug 20; 46(3):152-162. PubMed ID: 29519170
    [Abstract] [Full Text] [Related]

  • 16. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
    Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, Um SJ, Son CH.
    Allergol Immunopathol (Madr); 2015 Aug 20; 43(1):19-24. PubMed ID: 24388810
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May 20; 90(5):885-908. PubMed ID: 37516359
    [Abstract] [Full Text] [Related]

  • 18. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
    Matsuda H, Saito K, Takayanagi Y, Okazaki T, Kashima K, Ishikawa K, Kai Y, Takeo N, Hatano Y, Okamoto O, Fujiwara S.
    J Dermatol; 2013 Feb 20; 40(2):118-22. PubMed ID: 23216243
    [Abstract] [Full Text] [Related]

  • 19. Eosinophilia and Fever with Levetiracetam: A Case Report.
    Flannery AH, Willey MD, Thompson Bastin ML, Buch KP, Bensadoun ES.
    Pharmacotherapy; 2015 Aug 20; 35(8):e131-5. PubMed ID: 26235978
    [Abstract] [Full Text] [Related]

  • 20. Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).
    Silva SA, Figueiredo MM, Carneiro L, Reiss DB, Damásio MA.
    Rev Assoc Med Bras (1992); 2016 Aug 20; 62(3):227-30. PubMed ID: 27310545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.